Showing results (2561-2570 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 28, 2021
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumorsShivaani Kummar, Apurva K Srivastava, Tony Navas, et al.
Investigational New Drugs|February 3, 2020
The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancerXiaofeng Gong, Danyu Du, Yanran Deng, et al.
Investigational New Drugs|March 22, 2020
Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral bloodHolly A Maulhardt, Alyson M Marin, Gere S diZerega
Investigational New Drugs|March 15, 2020
Dezocine promotes T lymphocyte activation and inhibits tumor metastasis after surgery in a mouse modelQiang Song, Geng Liu, Dongyi Liu, et al.
Investigational New Drugs|September 19, 2020
Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transitionFu-Chun Huo, Wen-Tao Zhu, Xu Liu, et al.
Investigational New Drugs|September 26, 2020
Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myelomaNadire Özenver, Sara Abdelfatah, Anette Klinger, et al.
Investigational New Drugs|January 1, 1987
The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional studyJ A Thompson, A Fefer
Investigational New Drugs|January 3, 2021
Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft modelsFariba Shiravi, Mehdi Mohammadi, Forough Golsaz-Shirazi, et al.
Investigational New Drugs|January 11, 2021
Immunotherapy-induced pneumonitis in non-small cell lung cancer patients: current concern in treatment with immune-check-point inhibitorsZongqiong Sun, Sheng Wang, Hongdi Du, et al.
Investigational New Drugs|January 11, 2021
A rat toxicological study of intra-arterial injection of Tirapazamine, a hypoxia-activating Cancer therapeutic agent, followed by hepatic artery ligationChang-Hsien Liu, Shih-Ming Kuo, Hong-Wei Gao, et al.
Pageof 372